RVTY
RVTY
Revvity

Tariff Mitigation And Adaptation Will Unlock Life Sciences Potential

AN
AnalystLowTarget
AnalystLowTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
20 Apr 25
Updated
23 Jul 25
AnalystLowTarget's Fair Value
US$100.00
11.3% undervalued intrinsic discount
23 Jul
US$88.68
Loading
1Y
-26.1%
7D
-6.1%

Author's Valuation

US$100.0

11.3% undervalued intrinsic discount

AnalystLowTarget Fair Value

Narrative
Updates3